I just think it's an important piece of it because it seems like something is afoot here--that the manufacturers have--and drug companies have really been playing offense when it comes to 340B and I think it would be fair to take a look at their overcharges.
Castor expresses concern over drug manufacturers' practices regarding 340B overcharges.
Share
More from Kathy Castor
I thank Mrs. Dingell for yielding the time, and I thank Chairman Bilirakis for moving the bill forward to the floor today. I rise in strong support of H.R. 906, the Foreign Adversary Communications Transparency Act. This bill would require…
I thank the ranking member for yielding the time. Mr. Speaker, I rise in opposition to H.R. 7637. It is a Republican bill that is going to raise costs for hardworking American families. It is very emblematic of what they call this…
Mr. Speaker, I simply must call out some of the hypocrisy coming from my colleagues on the other side of the aisle. We have watched over the past few months as electricity costs for hardworking Americans have gone up. People are asking why…
I thank the ranking member for yielding the time. Mr. Speaker, I rushed to the floor this morning to oppose the rule and the underlying legislation because these Republican bills will raise electric bills on the families I represent back…
Other voices in this conversation
